BFM
VRNA
Boothbay Fund Management’s Verona Pharma VRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $45.7M | Buy |
482,909
+8,980
| +2% | +$849K | 0.89% | 3 |
|
2025
Q1 | $30.1M | Buy |
473,929
+41,759
| +10% | +$2.65M | 0.79% | 5 |
|
2024
Q4 | $20.1M | Buy |
432,170
+23,100
| +6% | +$1.07M | 0.5% | 23 |
|
2024
Q3 | $11.8M | Sell |
409,070
-446,328
| -52% | -$12.8M | 0.27% | 48 |
|
2024
Q2 | $12.4M | Buy |
855,398
+216,280
| +34% | +$3.13M | 0.29% | 42 |
|
2024
Q1 | $10.3M | Buy |
639,118
+571,194
| +841% | +$9.19M | 0.2% | 54 |
|
2023
Q4 | $1.35M | Buy |
67,924
+11,726
| +21% | +$233K | 0.03% | 525 |
|
2023
Q3 | $916K | Buy |
56,198
+4,914
| +10% | +$80.1K | 0.02% | 665 |
|
2023
Q2 | $1.08M | Buy |
51,284
+17,323
| +51% | +$366K | 0.02% | 650 |
|
2023
Q1 | $682K | Sell |
33,961
-3,928
| -10% | -$78.9K | 0.01% | 966 |
|
2022
Q4 | $990K | Sell |
37,889
-8,910
| -19% | -$233K | 0.02% | 740 |
|
2022
Q3 | $478K | Buy |
46,799
+8,519
| +22% | +$87K | 0.01% | 1096 |
|
2022
Q2 | $160K | Buy |
+38,280
| New | +$160K | ﹤0.01% | 1589 |
|